#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 5

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Parkinson's disease

Recruiting

Investigational

A study comparing prasinezumab with placebo for people with early-stage Parkinson's disease

Investigational

France

Participants:18–64 years · 65+ years
Substances:Prasinezumab

Contact Research Centre

Non-small cell lung cancer stage IIIA+2

Recruiting

Registered drugNo placebo

Testing MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Myasthenia gravis

Recruiting

Registered drug

Study of oral cladribine compared to placebo for patients with generalized myasthenia gravis

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Cladribine

Contact Research Centre

Severe myoclonic epilepsy of infancy

Recruiting

InvestigationalNo placebo

A study using MPPF imaging to examine serotonin pathways in the brainstem of patients with Dravet Syndrome epilepsy

InvestigationalNo placebo

France

Participants:18–64 years · Healthy volunteers
Substances:4-Fluoro-N-[2-[4-(2-Methoxyphenyl)Piperazin-1-Yl]Ethyl]-N-Pyridin-2-Ylbenzamide

Contact Research Centre

Multiple sclerosis

Recruiting

Registered drug

A study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis

Registered drug

France

Participants:18–64 years
Substances:Ocrelizumab

Contact Research Centre

Pulmonary hypertension

Recruiting

Investigational

Testing Treprostinil Palmitil Inhalation Powder for Improving Exercise Ability in Patients with Pulmonary Hypertension Related to Interstitial Lung Disease

Investigational

France

Participants:18–64 years · 65+ years
Substances:Treprostinil Palmitil

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Testing zongertinib compared to standard treatment in patients with early-stage non-small cell lung cancer with HER2 mutations after surgery

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Sepsis

Recruiting

Registered drugNo placebo

Testing a Drug Combination for Personalized Sepsis Treatment in Children and Adults with Severe Blood Infection

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Anakinra

Contact Research Centre

Trisomy 21

Recruiting

Investigational

Study of AEF0217 compared to placebo for improving behavior and thinking skills in adults and older adolescents with Down syndrome

Investigational

France

Participants:0–17 years · 18–64 years
Substances:1-((3S,8S,9S,10R,13S,14S,17S)3-BENZYLOXY-10,13,17-TRIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1HCYCLOPENTA[A]PHENANTHRENE-17-YL)ETHAN-1-ONE

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Recruiting

Registered drugNo placebo

Study of ribociclib with or without chemotherapy for patients with hormone receptor positive, HER2 negative early breast cancer at intermediate risk

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Diabetes mellitus

Recruiting

Investigational

A Study of Teplizumab Compared to Placebo for Blood Sugar Control in Children and Young Adults Aged 1 to 25 Years with Newly Diagnosed Type 1 Diabetes

Investigational

France

Participants:0–17 years · 18–64 years
Substances:Teplizumab

Contact Research Centre

Astrocytoma malignant

Recruiting

Investigational

Vorasidenib for patients with IDH-mutant grade 2 or 3 astrocytoma after completing first-line chemoradiotherapy

Investigational

France

Participants:18–64 years · 65+ years
Substances:Vorasidenib

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.